Zhaoxiao Yu, Zhikun Wu, Dejian Liu, Haoyu Liu, Yu Zhang, Yaqian Zheng, Yanhong Huang, Shumin Liao, Yu Wei, Wei Huang, Zhenyu Zhang, Xi Liu, Haiying Yu, Di Wang, Liang Li, Feng Long, Luyan Z. Ma
{"title":"Dual-function regulator MexL as a target to control phenazines production and pathogenesis of Pseudomonas aeruginosa","authors":"Zhaoxiao Yu, Zhikun Wu, Dejian Liu, Haoyu Liu, Yu Zhang, Yaqian Zheng, Yanhong Huang, Shumin Liao, Yu Wei, Wei Huang, Zhenyu Zhang, Xi Liu, Haiying Yu, Di Wang, Liang Li, Feng Long, Luyan Z. Ma","doi":"10.1038/s41467-025-57294-8","DOIUrl":null,"url":null,"abstract":"<p>Antibiotic resistance or tolerance of pathogens has become one of the global public crises. Finding new drug targets may open up a way of infection control. Phenazine pyocyanin (PYO) is an important virulence factor produced by the pathogen <i>Pseudomonas aeruginosa</i>. Here we show that a multidrug efflux pump repressor, MexL, acts as a transcriptional activator to enhance phenazines production via binding with a conserved DNA motif within the promoters of phenazines biosynthesis genes. Moreover, PYO functions as a self-regulating ligand of MexL for restricting its own production and the <i>mexL</i> knockout attenuates the virulence and antibiotics tolerance of <i>P. aeruginosa</i>. Based on the structure of MexL we resolve, we find two antimicrobials that can interact with MexL to reduce the PYO production and virulence of <i>P. aeruginosa</i>. Our in vivo studies suggest that the antimicrobials combination by using MexL-antagonists to reduce bacterial virulence and enhance the efficacy of common antibiotics can be an effective way to combat <i>P. aeruginosa</i> infection.</p>","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"51 1","pages":""},"PeriodicalIF":14.7000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Communications","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1038/s41467-025-57294-8","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Antibiotic resistance or tolerance of pathogens has become one of the global public crises. Finding new drug targets may open up a way of infection control. Phenazine pyocyanin (PYO) is an important virulence factor produced by the pathogen Pseudomonas aeruginosa. Here we show that a multidrug efflux pump repressor, MexL, acts as a transcriptional activator to enhance phenazines production via binding with a conserved DNA motif within the promoters of phenazines biosynthesis genes. Moreover, PYO functions as a self-regulating ligand of MexL for restricting its own production and the mexL knockout attenuates the virulence and antibiotics tolerance of P. aeruginosa. Based on the structure of MexL we resolve, we find two antimicrobials that can interact with MexL to reduce the PYO production and virulence of P. aeruginosa. Our in vivo studies suggest that the antimicrobials combination by using MexL-antagonists to reduce bacterial virulence and enhance the efficacy of common antibiotics can be an effective way to combat P. aeruginosa infection.
期刊介绍:
Nature Communications, an open-access journal, publishes high-quality research spanning all areas of the natural sciences. Papers featured in the journal showcase significant advances relevant to specialists in each respective field. With a 2-year impact factor of 16.6 (2022) and a median time of 8 days from submission to the first editorial decision, Nature Communications is committed to rapid dissemination of research findings. As a multidisciplinary journal, it welcomes contributions from biological, health, physical, chemical, Earth, social, mathematical, applied, and engineering sciences, aiming to highlight important breakthroughs within each domain.